Extensive Within-Host Diversity in Fecally Carried Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli Isolates: Implications for Transmission Analyses. by Stoesser, N et al.
Extensive Within-Host Diversity in Fecally Carried Extended-
Spectrum-Beta-Lactamase-Producing Escherichia coli Isolates:
Implications for Transmission Analyses
N. Stoesser,a,b A. E. Sheppard,b C. E. Moore,b T. Golubchik,b C. M. Parry,c,d,e P. Nget,f M. Saroeun,f N. P. J. Day,e A. Giess,b
J. R. Johnson,g,h T. E. A. Peto,a,b D. W. Crook,a,b A. S. Walker,b the Modernizing Medical Microbiology Informatics Groupb
Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdoma; NIHR Biomedical Research Center, University of Oxford/Oxford University
Hospitals NHS Trust, Oxford, United Kingdomb; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdomc; School of
Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japand; Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailande; Angkor Hospital for
Children, Siem Reap, Cambodiaf; Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota, USAg; Department of Medicine, University of Minnesota,
Minneapolis, Minnesota, USAh
Studies of the transmission epidemiology of antimicrobial-resistant Escherichia coli, such as strains harboring extended-spec-
trum beta-lactamase (ESBL) genes, frequently use selective culture of rectal surveillance swabs to identify isolates for molecular
epidemiological investigation. Typically, only single colonies are evaluated, which risks underestimating species diversity and
transmission events. We sequenced the genomes of 16 E. coli colonies from each of eight fecal samples (n 127 genomes; one
failure), taken from different individuals in Cambodia, a region of high ESBL-producing E. coli prevalence. Sequence data were
used to characterize both the core chromosomal diversity of E. coli isolates and their resistance/virulence gene content as a proxy
measure of accessory genome diversity. The 127 E. coli genomes represented 31 distinct sequence types (STs). Seven (88%) of
eight subjects carried ESBL-positive isolates, all containing blaCTX-M variants. Diversity was substantial, with a median of four
STs/individual (range, 1 to 10) and wide genetic divergence at the nucleotide level within some STs. In 2/8 (25%) individuals, the
same blaCTX-M variant occurred in different clones, and/or different blaCTX-M variants occurred in the same clone. Patterns of
other resistance genes and common virulence factors, representing differences in the accessory genome, were also diverse within
and between clones. The substantial diversity among intestinally carried ESBL-positive E. coli bacteria suggests that fecal sur-
veillance, particularly if based on single-colony subcultures, will likely underestimate transmission events, especially in high-
prevalence settings.
Escherichia coli is considered an opportunistic pathogen of hu-mans: although capable of causing a wide spectrum of clinical
disease, it is carried asymptomatically in the gastrointestinal tract
of90% of individuals (1). The emergence and spread of antimi-
crobial resistance in E. coli is facilitated by its existence within the
gut reservoir (2–4). The recent threat of broad-spectrum antibi-
otic resistance, such as that mediated by extended-spectrum beta-
lactamases (ESBLs) (5), has prompted the introduction of fecal
surveillance in an attempt to track drug-resistant organisms epi-
demiologically and deploy infection control measures to limit
their spread (6, 7). Although ESBL-positive E. coli carriage preva-
lence varies from 10% to 70%, depending on the setting, it
appears to be on the increase globally in all contexts, including in
the community (8).
Current surveillance of the transmission of drug-resistant En-
terobacteriaceae tends to focus on tracking the spread of individual
clones (9), but whether this represents typical ESBL-positive E. coli
carriage and transmission remains unclear. Our understanding of
transmission is complicated by the fact that surveillance studies
have used different approaches, varying in their (i) sampling time
frames and strategies (7, 10, 11), (ii) methods of selective culture
of drug-resistant colonies from rectal swabs (12), and (iii) pheno-
typic/molecular methods used to subsequently characterize
strains (12, 13), with these methods themselves varying in their
screening sensitivity and specificity. At odds with the single-col-
ony approach is the fact that previous studies have demonstrated
that the molecular diversity of E. coli bacteria carried in the gas-
trointestinal tract is likely to be substantial, both between and
within individual human hosts (14, 15). Molecular typing of single
clones may therefore be inappropriate for characterizing trans-
mission, particularly in areas of high resistance prevalence where
individuals may carry multiple distinct clones with the same resis-
tance phenotype. Additionally, previous studies of intrahost strain
diversity have investigated only short molecular targets, using
techniques such as phylogrouping, random amplified polymor-
phic DNA (RAPD) analysis, or multilocus sequence typing
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(MLST) (6, 7, 14, 15), and may therefore have underestimated the
extent of genetic diversity present.
Whole-genome sequencing (WGS) is a high-resolution typing
technology that has been used successfully to describe within-host
population structures of several bacterial pathogens, such as
Staphylococcus aureus (16, 17). In this study, we used WGS as a
single assay to sample genetic diversity in core and accessory ge-
nomes of E. coli in fecal samples taken from asymptomatic carriers
in a community with high ESBL carriage prevalence (8).
(These data were presented in part at the 24th European Con-
gress of Clinical Microbiology and Infectious Diseases, Barcelona,
Spain, 10 to 13 May 2014 [18].)
MATERIALS AND METHODS
Sample description. Fecal samples from eight randomly selected individ-
uals, 13 to 14 years of age (considered to have adult fecal microflora), were
investigated. These individuals were enrolled in a much larger study to
estimate regional pediatric helminth prevalence (April to June 2012) un-
dertaken at the Cambodia-Oxford Medical Research Unit (COMRU),
Angkor Hospital for Children, in Siem Reap, Cambodia. To minimize
microbial loss, the samples were stored immediately after collection as
fecal slurries in saline with 10% glycerol at80°C (19). The local hospital
Institutional Review Board ([IRB] date of approval, 12 March 2012) and
the Oxford Tropical Research Ethics Committee ([OXTREC] reference
number 12-12) approved the wider research use of these samples.
Laboratory methods. For each fecal slurry, 5 l of neat sample, and
of 1:5 and 1:100 dilutions was streaked evenly across individual
CHROMagar Orientation agar plates (Becton Dickinson UK, Oxford,
United Kingdom) and then incubated in air at 37°C overnight after place-
ment of a cefpodoxime disc (10 g; Oxoid, Basingstoke, United King-
dom) on each plate. E. coli isolates are typically represented as pink colo-
nies on CHROMagar Orientation agar.
For each sample, a dilution plate was selected on which growth was
sparse enough to enable 16 single-colony picks of discrete pink colonies
(presumptive E. coli), which were subcultured onto separate Columbia
FIG 1 Genetic characteristics of Escherichia coli carriage isolates from subject IHD244 (A), subject IHD86 (B), subject IHD232 (C), subject IHD357 (D), and
subject IHD45 (E). Black circles at tree nodes indicate bootstrap values of95%. Colored circles represent genetic similarity of isolates within STs and are sized
and labeled according to the number of isolates sharing identity. Branches between circles represent a core, single nucleotide variant. Labels adjacent to circles
represent blaCTX-M variants (colored by variant type). Within-host resistance and virulence gene profiles are represented in the heat map at the bottom of each
panel, with colored blocks representing presence and gray blocks representing absence of a gene. Resistance genes are represented as red blocks; virulence factors
are colored by functional category (sea green, adhesins; olive, toxins; light blue, nutritional factors; dark blue, immune evasion; lilac, miscellaneous). Isolates from
within the cefpodoxime zones are labeled 1 to 8 (e.g., IHD244_1) and those from outside the zones are labeled 9 to 16 (e.g., IHD244_9), where applicable.
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blood agar plates. These included up to eight colonies from within the
inhibition zone around the antibiotic disc (if observed), with the balance
taken from outside the inhibition zone. Plates were incubated overnight
in air at 37°C.
DNA extraction and sequencing. DNA was extracted from the sub-
cultures using a QuickGene kit (Fujifilm, Minato, Tokyo, Japan) accord-
ing to the manufacturer’s instructions, with an additional mechanical lysis
step (FastPrep; MP Biomedicals, Santa Ana, USA) following the addition
of chemical lysis buffer. Sequencing was carried out on an Illumina HiSeq
2500 platform, generating 100- or 151-base-paired end reads (see Table S1
in the supplemental material).
Sequence read processing and data analysis. Reads were mapped to
the CFT073 E. coli reference genome (NCBI RefSeq NC_004431), and
variants were called using a validated in-house bioinformatics pipeline
(20). Reads were also assembled de novo using Velvet and the Velvet-
Optimiser wrapper (21, 22).
Multilocus sequence type (ST) and resistance/virulence gene content
were determined in silico using BLASTn-based comparisons of reference
alleles and de novo-assembled contigs for each isolate. For MLST we used
the scheme and reference database of Wirth et al. (23); for resistance
genes, an in-house database of curated resistance genes and variants (24)
was used, and for virulence genes, a further in-house database compiled
for this study from the Virulence Factors Database (VFDB) (25) and re-
view papers (26, 27) was used. Virulence factors were subdivided into
functional categories as follows: adhesins, toxins, nutritional, immune
evasion-related, and miscellaneous (26). Multiple BLAST hits to overlap-
ping positions on the same contigs were ignored, and only the best hit was
retained; gene presence was arbitrarily defined as 80% sequence simi-
larity over80% of the length of the reference locus (i.e., coverage of the
reference sequence of80%).
Bootstrapped maximum likelihood phylogenies were derived from
core chromosomal single nucleotide variants (SNVs; core SNVs defined as
no null call in any isolate at that site from reference-based mapping) using
PhyML (28). To scale trees appropriately, core SNVs for each isolate were
reinserted into the reference CFT073 sequence, thereby generating an
alignment of modified reference sequences of all the isolates for compar-
ison.
Diversity was assessed first with respect to the core genome, using
reference-mapped data, and second with respect to the small part of the
accessory genome represented by the resistance/virulence genes described
above. To avoid skewed results from repeated sampling of essentially the
same organism, comparisons were made across all isolates and across all
clones plus singletons. Here, a clone was defined as a set of at least two
isolates from a given individual, where each isolate differed by no more
than two core SNVs from at least one other isolate in the clone. No isolates
had 3 to 10 SNV differences. Singletons were defined as any isolates that
FIG 1 continued
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were not part of a clone. Our definition of a clone is independent of ST.
The SNV cutoff defining a clone is arbitrary but conservative, given the
extent of diversity observed in E. coli (29), and is consistent with SNV
differences observed within hosts over 6 to 12 months for Clostridium
difficile, another gastrointestinal organism with a similar mutation rate
but far less intrahost diversity (30, 31). The accessory genome, represented
here only by the particular resistance and virulence genes surveyed, was
defined as homogeneous for a clone if every sequenced isolate within the
clone had the same profile or as heterogeneous if these traits varied.
To assess whether genes present in the accessory genome were more
likely to be similar across genetically distinct strains (represented here by
clones and/or singletons [clones/singletons]) within an individual than
strains between individuals, we generated a distance matrix from pairwise
comparisons of the accessory gene content for each clone or singleton (as
defined by the complete profile of resistance/virulence genes present in
any isolate of that clone or singleton). The statistical significance of the
difference in accessory gene diversity among strains within individuals
versus strains between individuals was then calculated using a Wilcoxon
rank sum test. This analysis tests the hypothesis that horizontal gene trans-
fer of specific resistance/virulence genes is likely to be occurring with
greater frequency within the gastrointestinal tract of individuals. Statisti-
cal analyses were carried out in Stata/SE, version 11.2 (StataCorp., Texas,
USA).
Microarray data accession number.Data were deposited in the NCBI
under BioProject number PRJNA274331. Details of sequenced strains and
data accession numbers are provided in Table S1 in the supplemental
material.
RESULTS
Of eight samples, five came from female individuals; the median
age was 13.4 years (interquartile range [IQR], 13.2 to 13.7 years).
Six samples were obtained from children subsequently admit-
ted to the inpatient department, and two were from patients
reviewed in the outpatient department of the hospital (IHD45
and IHD717). Three children had underlying blood dyscrasias
(thalassemia, subject IHD244; leukemia, subjects IHD232 and
IHD813), and one had valvular heart disease (subject IHD1178).
Details on previous antibiotic usage were not available; all indi-
viduals except subject IHD232 had exposure to either companion
animals or livestock/poultry in the household.
The fecal cultures yielded presumptive cefpodoxime-resistant
E. coli colonies within the peridisk inhibition zone for five of eight
subjects (Table 1) (subjects IHD86, IHD244, IHD357, IHD813,
and IHD1178). For these five subjects, simple random sampling of
FIG 1 continued
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eight presumptive E. coli colonies from within and eight from
outside the inhibition zone was undertaken (n 16 per sample).
For the remaining three subjects (IHD45, IHD232, and IHD717),
the primary culture plates had no within-zone E. coli colonies, so
16 colonies were picked from outside the zone. The resulting total
128 colonies underwent genome sequencing, which failed for one
isolate, leaving 127 genome sequences for analysis.
The median number of high-quality reads available for map-
ping per isolate was 3,159,616 (range, 1,510,888 to 4,777,836).
This provided 70% coverage of the reference genome (median
coverage, 73%; range, 71 to 79%), consistent with all isolates being
E. coli. The median de novo assembly size was 4,818,355 bp (range,
4,513,031 to 5,306,174 bp), with a median 187 contigs (range, 76
to 422).
In silicomultilocus sequence typing. In silico MLST identified
BLAST matches for all E. coli housekeeping loci in all 127 isolates,
including novel fumC, purA, and recA variants (one each). In total,
the 127 sequenced genomes represented 31 STs (of which 6 were
novel). Across all study participants, 18 clones were identified
(collectively comprising 108 isolates), whereas 19 isolates were
singletons, representing 18 different STs.
The STs were distributed unevenly across the eight fecal sam-
ples, which contained 1 to 10 (median, 4) STs each. ST-405 was
carried by three individuals, and ST-10 and ST-155 were carried
by two individuals each. The other STs were all identified in a
single individual each (Table 1). Despite analysis of 16 colonies per
subject, the 37 clones plus singletons were also unevenly distrib-
uted across the eight samples, which had 1 to 11 (median, 4) clones
plus singletons each.
Determination of genotypes accounting for cefpodoxime re-
sistance. A blaCTX-M variant was detected in all 40 presumptive
cefpodoxime-resistant isolates picked from within the peridisk
cefpodoxime inhibition zone for the five samples with such colo-
nies; this presumably explained these samples’ cefpodoxime-resis-
tant phenotypes. Additionally, for two of the three samples that
yielded no colonies within the cefpodoxime inhibition zone, a
blaCTX-M variant was detected in 1/16 colonies (per sample)
picked from outside the inhibition zone. Thus, at least 7/8 (88%)
individuals carried blaCTX-M genes. In two individuals (subjects
IHD86 and IHD1178), the same blaCTX-M variant was observed in
genetically distinct isolates. Specifically, in subject IHD1178,
blaCTX-M-15 was found in three clones plus singletons, whereas in
subject IHD86, blaCTX-M-55 was found in four different clones plus
singletons, and blaCTX-M-14 was found in 2 clones plus singletons.
Furthermore, in IHD86, both blaCTX-M-55 and blaCTX-M-14 were
observed within the same clone (ST-2535) (Table 1).
FIG 1 continued
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Analysis of within-host E. coli core and accessory genome
diversity. The number of SNVs between isolates from a single
individual ranged from 1 to 144,651 (Fig. 1A to E, within-host
diversity; see also Fig. S1A to C in the supplemental material). The
genetic diversity observed between clones/singletons was invari-
ably1,000 SNVs, reflecting the extensive diversity recognized as
being present in the species (29). A variety of E. coli population
structures were identified in human carriers. However, only one
individual carried a monoclonal population; in this instance, all 16
isolates represented a single ST (ST-10), and a single core chro-
mosomal SNV separated one isolate from the rest. In addition, all
isolates from this individual carried blaCTX-M-55 and had a homo-
geneous accessory component (see Fig. S1A in the supplemental
material). In all other individuals, multiple STs were present, with
at least one clone observed in each case.
A range of patterns was observed in the accessory genome, as
represented by resistance and virulence genes. From the perspec-
tive of the clone, in total 11 clones (from seven individuals) had
homogeneous accessory components, and seven clones (from five
individuals) had heterogeneous accessory components. From the
perspective of the individual, three individuals had clones with
only homogeneous accessory components (Fig. 1A; see also Fig.
S1A and B in the supplemental material), one had clones with only
heterogeneous accessory components (Fig. 1C), and four had
clones with both homogeneous and heterogeneous accessory
components (Fig. 1B, D, and E; see also Fig. S1C).
Six of 18 clones showed observable diversity at the core
genome level, in association with which the accessory genome
could be either heterogeneous (Fig. 1B to E; see also Fig. S1A)
or homogeneous (Fig. 1B; see also Fig. S1A). Additionally, two
individuals had isolates of the same ST with substantial varia-
tion in the core genome; i.e., it exhibited within-ST SNV dif-
ferences of 4,411 (Fig. 1E) and 11,315 (see Fig. S1C in the
supplemental material). Notably, in the latter case, the acces-
sory genome was invariant.
More extensive accessory genome diversity was observed
among strains recovered from different individuals than observed
in strains recovered from within a single individual (Fig. 2). Based
on pairwise comparisons of accessory gene content in strains, the
median pairwise interstrain difference was 0.17 (IQR, 0.09 to 0.25)
between individuals versus 0.11 (IQR, 0.04 to 0.19) within indi-
viduals (P 0.0001).
FIG 1 continued
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DISCUSSION
Significance of the study and implications for transmission
studies of intestinally carried CTX-M-positive E. coli. This work
represents, to our knowledge, the first WGS-based analysis of
within-host fecal diversity of E. coli. Given the increasing impor-
tance of antimicrobial resistance in E. coli, we chose to focus on
sampling individuals in a region where ESBL-producing E. coli is
endemic. Although we sampled only a small group of human hosts
(n 8 individuals) from a single geographic location, the extent of
diversity observed among ESBL-producing E. coli isolates was
substantial. In addition, this diversity existed at multiple levels, as
follows: (i) at the isolate level (Fig. 1E) (up to 10 STs present when
16 colonies are sampled); (ii) at the ST level, where the same ST
was separated by large numbers of SNVs (Fig. 1E; see also Fig.
S1C); (iii) the level of accessory gene content (here represented by
resistance and virulence genes), with mosaicism of individual
genes across a clone (Fig. 1C); and (iv) the level of resistance genes,
such as blaCTX-M, with different variants present within a host or
even an ST (Fig. 1B).
Because an individual may carry multiple antimicrobial-resis-
tant genotypes, typing of a single resistant colony per host, by any
method, is inadequate to rule out transmission. This may be less of
an issue in countries and hospital settings where resistance prev-
alence is low and where ongoing dissemination of a single, resis-
tant “outbreak” clone may be more likely. However, even if the
diversity of ESBL-producing E. coli bacteria is currently restricted
in such settings and if outbreaks are generally clonal, the situation
may change as resistance prevalence continues to increase (8).
Here, we sequenced 16 individual colonies per fecal sample,
which is highly resource intensive and, therefore, impracticable
for routine surveillance. A previous study of Clostridium difficile
demonstrated the successful use of sequencing mixtures of multi-
ple colonies to estimate prevalence in fecal samples, to identify
multiple-strain infection/colonization, and to type individual
strains by in silico MLST (30). However, the expectation in that
study, based on multiple-pick experiments similar to those con-
ducted here, was that mixtures of no more than two subtypes were
likely to be encountered. Given the extent of diversity identified in
intestinal E. coli bacteria both here and in previous studies of En-
terobacteriaceae (14), the methods used by Eyre et al. (30) would
be inappropriate for these organisms in the vast majority of cases.
More complex methods would be required to disentangle the
complex population structures from short-read sequencing of
mixed subcultures, if this is even possible.
One interesting question is what is the most appropriate de-
nominator to use for calculating diversity in studies such as this.
Our sampling frame should mean that, in principle, the isolates
reflect the underlying frequency distribution of organisms present
in each host, which is at least conditional on the sampling strategy,
which here deliberately oversampled resistant organisms. Assum-
ing each organism present has the same probability of being trans-
mitted, by-isolate prevalence could be argued to reflect the trans-
mission pressure most reliably. However, in all individuals at least
2 of the 16 sequenced colonies, and commonly appreciably more,
were essentially identical at the core strain level; consequently, we
also used a second denominator, clones plus singletons, to better
reflect the diversity of discrete organisms present in the eight car-
riers.
Limitations of the study. An important limitation of the study
was the inability to assess these isolates for the diversity of their
mobile genetic elements, such as plasmids, in view of the difficulty
in assembling these structures from short-read data. There is likely
additional diversity at this level and/or shared plasmids within and
among STs. Indeed, our analysis suggests that the across-clone
similarity of E. coli accessory genomes is greater within than be-
tween individuals even when widely divergent isolates are present
in a given host, supporting the hypothesis that horizontal gene
transfer is occurring within individual hosts. This hypothesis
could be further investigated by fully assembling plasmid popula-
tions using a long-read sequencing method, which would clarify
the extent of plasmid transfer among genetically distinct strains
within individuals.
We also made no specific comparisons with other typing meth-
ods, such as pulsed-field gel electrophoresis (PFGE) or RAPD
analysis. However, PFGE has already been shown to have a lower
typing resolution than WGS (32). Similarly, although the authors
of a recent comparison of WGS with RAPD for the typing of fecal
colonies concluded that RAPD analysis successfully identified iso-
lates described as clonal by WGS (33), their definition of “clonal”
was substantially less stringent than ours, allowing for up to 0.05%
SNV differences across 1,776 single-copy core genes, conceivably
representing several hundred SNVs and a significant evolutionary
distance. The degree to which the additional resolution afforded
by WGS substantively alters study findings and conclusions will
ultimately depend on the specific question being addressed, but it
enabled us to assay genetic variation at multiple, different levels
using one assay.
While WGS represents a singular, unifying method by which to
classify a range of genetic characteristics, the typing of multiple
subcolonies using WGS is not an approach that is currently appli-
cable to field use, and this study did not aim to identify an alter-
native, high-resolution, practicable method. Nevertheless, our
findings have important implications for transmission studies of
FIG 2 Pairwise distance comparisons of differences in the accessory gene
component in clones/singletons between and within study subjects. Each dot
represents a single pairwise comparison of differences in accessory gene con-
tent between each set of clones/singletons, depending on whether these strains
were present in the same individual (within) or in different individuals (be-
tween). Gray lines represent the median pairwise difference for each subgroup;
dotted gray lines represent the upper and lower quartiles for each subgroup.
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ESBL-producing E. coli in that if surveillance is dependent on
characterizing only one or several resistant colony/colonies per
sample for clonal background, resistance genes, other accessory
traits, or some combination thereof, important transmission
events could be missed. Our data highlight the need to character-
ize multiple resistant isolates per sample, by whatever typing
method, to capture the diversity relevant to transmission of resis-
tant strains.
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